Detailed DSM Plan Checklist
Download this file (PDF, 12KB)
| Was item included in the DSM plan? | Included? | |
|---|---|---|
| Yes | No | |
| Brief description of the protocol | ||
| Primary and secondary outcome measures | ||
| Inclusion/exclusion criteria | ||
| Sample size | ||
| List of participating enrolling clinics or data collection centers | ||
| Projected timetable | ||
| Target population distribution (e.g., women, minorities, etc) | ||
| Data acquisition and transmission | ||
| Data entry methods | ||
| Data analysis plan | ||
| Quality assurance plan | ||
| Reporting mechanisms of AEs/SAEs to the IRB, FDA, and NIDA. | ||
| Reporting mechanisms of IRB actions to NIDA | ||
| Report of changes or amendments to the protocol | ||
| Trial stopping rules | ||
| Conflict of interest | ||
| Potential risks and benefits for participants | ||
| Collection and reporting of AEs and SAEs | ||
| Management of SAEs or other study risks | ||
| Plans for Interim Analysis of efficacy data | ||
| Responsibility for data and safety monitoring | ||
| Frequency of DSM reviews | ||
| Content of DSM report | ||
| DSM Board Plan (if applicable) | ||
Attention
Due to the lapse in government funding, the information on this web site may not be up to date, transactions submitted via the web site may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. Updates regarding government operating status and resumption of normal operations can be found at
Looking for Treatment?
Use the SAMHSA Treatment Locator or 1-800-662-HELP.
Helpline open during government shutdown
Featured Publication
Mentoring: A Guide for Drug Abuse Researchers
Discusses the importance of quality mentorship in drug abuse research and offers suggestions for creating a successful mentor and mentee relationship.